CORE
🇺🇦
make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Immune related adverse events as a biomarker in non-melanoma patients treated with programmed death 1 inhibitors (PD-1Is).
Author
Daniel M. Geynisman
Elizabeth Handorf
+10 more
Elizabeth R. Plimack
Hossein Borghaei
Jamie Doyle
Jessica Ruth Bauman
John O'Neill
Julia Judd
Matthew R. Zibelman
Ranee Mehra
Robert G. Uzzo
Sasini Bentota
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Immune‐Related Adverse Events as a Biomarker in Non‐Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors
Author
Chethan Ramamurthy
Daniel M. Geynisman
+15 more
Downey SG
Elizabeth Handorf
Elizabeth R. Plimack
Hossein Borghaei
Jamie Doyle
Jessica Bauman
John O'Neill
Julia Judd
Matthew Zibelman
Mian I
Prior LM
Ranee Mehra
Robert G. Uzzo
Sasini Bentota
Weber JS
Publication venue
'Alphamed Press'
Publication date
Field of study
No full text
Crossref
No full text
